AQST News

AQST Deadline: AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit

Class Action Reminder from Pomerantz LLP for Investors of Aquestive Therapeutics, Inc. – AQST

AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!

AQST DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 4 Deadline in Securities Class Action - AQST

AQST DEADLINE: ROSEN, HIGHLY RECOGNIZED INVESTOR RIGHTS COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 4 Deadline in Securities Class Action – AQST

Class Action Lawsuit Reminder from Pomerantz LLP for Shareholders of Aquestive Therapeutics, Inc. – AQST

AQST INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026 Ready to Announce with Confidence?

ODD INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Oddity Tech (ODD) Investors of Securities Class Action Deadline on May 11, 2026 Ready to Announce with Confidence?

AQST DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important May 4 Deadline in Securities Class Action - AQST

AQST Shareholder Alert: Aquestive Therapeutics, Inc. Securities Class Action Lawsuit - Investors Should Contact The Gross Law Firm